Kyowa Kirin Co., Ltd. (TYO:4151)
Japan · Delayed Price · Currency is JPY 2,401.50
+13.50 (0.57%)
May 26, 2026, 2:35 PM JST
Kyowa Kirin Earnings Call Transcripts
Fiscal Year 2025
-
Revenue and profits declined year-over-year due to restructuring and special retirement costs, but key products like Crysvita and Poteligeo showed strong growth in North America and EMEA. R&D pipeline advanced with promising data for Ziftomenib and Rocatinlimab, and AI-driven strategies are boosting market penetration.